[Treatment of cardiac insufficiency. 2].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001682:Biological Availability; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D004071:Digitalis Glycosides / Q000506:poisoning; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D002301:Cardiac Glycosides; D004071:Digitalis Glycosides
Behandlung der Herzinsuffizienz Teil 2.